Results 311 to 320 of about 543,327 (389)

Prediction of neutrophil nadir and recovery following paediatric haematopoietic cell transplantation with busulfan conditioning

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims In haematopoietic cell transplantation (HCT), neutropenia resulting from myelosuppression is an expected endpoint following busulfan‐based conditioning. However, if prolonged, neutropenia can lead to complications like serious infection and death.
Beth Apsel Winger   +6 more
wiley   +1 more source

Using a SPOT ROI Function to Minimize Radiation During Chronic Total Occlusion Percutaneous Coronary Interventions. [PDF]

open access: yesJACC Case Rep
Yoshinaga M   +9 more
europepmc   +1 more source

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Clopidogrel, an antiplatelet agent, is currently licensed in the United Kingdom for the prevention and treatment of atherothrombotic events in cerebrovascular disease, coronary artery disease and peripheral arterial disease. Clopidogrel requires metabolic activation by the cytochrome P450 enzyme CYP2C19 to be effective.
Cinzia Dello Russo   +22 more
wiley   +1 more source

Impact of diabetes mellitus and body mass index on long-term survival in chronic total occlusion patients: a nationwide cohort study from the SCAAR registry. [PDF]

open access: yesBMJ Open
Mohammed M   +17 more
europepmc   +1 more source

Percutaneous Coronary Intervention for a Chronic Total Occlusion Caused by an External Pacemaker Lead Placement. [PDF]

open access: yesJACC Case Rep
Kharsa C   +9 more
europepmc   +1 more source

Research frontiers and hotspots of coronary chronic total occlusion: A bibliometric analysis. [PDF]

open access: yesMedicine (Baltimore)
Li S   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy